The latest COVID-19 test from healthcare tech producer Abbott is the fastest, when it comes to producing results, and can carry out tests the spot at point-of-care, without requiring a round trip to a lab.
This test for the novel coronavirus causing the current international pandemic has received emergency clearance to be used by the U.S. Food and Drug Administration (FDA). It can start production next week, with an output of 50,000 per day possible beginning next week.
The new Abbott ID NOW COVID-19 test uses the Abbott ID NOW diagnostics platform, which is essentially a lab-in-a-field that’s approximately the dimensions of a small kitchen appliance. It’s size, and the fact that it can produce both a positive result in just five minutes means that it could be a really useful means to extend coronavirus testing past its current availability to new places together with clinics and doctor’s workplaces and reduce on wait times in terms of getting tested and receiving a diagnosis.
In contrast to the rapid tests which have been utilized in other nations, and that obtained a new type of authorization under an FDA guideline that doesn’t verify the accuracy fo the results.
This means that it works by identifying a portion of the virus’ DNA in a patient, which implies it’s much better at detecting the precise presence of the virus during infection, whereas other tests that search the blood for antibodies which might be utilized in point-of-care settings can detect antibodies, which may be present in recovered sufferers who don’t have the virus.